Authors and Affiliations John Stagg , David Allard . About John Stagg "John Stagg is a Professor of Pharmacy at Université de Montréal and researcher at the Distinguished immunologist, Dr Stagg is recognized for having identified the adenosine-producing enzyme Dr Stagg has served as an expert consultant in the development of adenosine-targeting drugs, several John Stagg on the web University of Montréal Québec Cancer Consortium The University of Montreal Hospital

Welcome Remarks Read More Thursday, November 2nd / 1:45 PM - 2:45 PM Trainee Symposium I Eric Johansen , Johns University Read More Friday, November 3rd / 4:35 PM Targeting adenosine signaling for immuno-oncology John Stagg CHUM, Université de Montréal Read More Friday, November 3rd / 5:00 PM Poster Session #2 Read More

John Streicher About this episode Our guest in this episode of the Dr.GPCR podcast is Dr. John Streicher from the department of pharmacology at the University of Arizona. John started grad school in 1999 and spent some time figuring out what he was interested in. Today, John and his team focus on understanding how signal transduction cascades downstream of the opioid John Streicher on the web University of Arizona Department of Pharmacology Google Scholar Pubmed LinkedIn

John Streicher from the department of pharmacology at the University of Arizona. John started grad school in 1999 and spent some time figuring out what he was interested in. Laura Bohn’s lab at Scripps Research Institute in Florida. Today, John and his team focus on understanding how signal transduction cascades downstream of the opioid John Streicher on the web University of Arizona Department of Pharmacology Google Scholar Pubmed LinkedIn

John Janetzko About Dr. John Janetzko "I received my Honors BSc in Chemistry from the University of Toronto in 2011, with a focus To further develop these ideas, I joined the lab of Dr. In July 2024 I will join the University of Colorado, Anschutz Medical Campus, as an Assistant Professor John Janetzko on the web Stanford University Stanford Medicine Google Scholar Personal Website ResearchGate

John Janetzko "I received my Honors BSc in Chemistry from the University of Toronto in 2011, with a focus To further develop these ideas, I joined the lab of Dr. In July 2024 I will join the University of Colorado, Anschutz Medical Campus, as an Assistant Professor John Janetzko on the web Stanford University Stanford Medicine Google Scholar Personal Website ResearchGate

Jennifer is currently an assistant professor of physiology at the Johns Hopkins School of Medicine. Jennifer Pluznick on the web John Hopkins Pluznick Lab Pubmed Ted Talk Dr.

Jennifer is currently an assistant professor of physiology at the Johns Hopkins School of Medicine. Jennifer Pluznick on the web John Hopkins Pluznick Lab Pubmed Ted Talk Dr.

During a joint postdoc with John W Daly at NIH and Solomon Snyder at Johns Hopkins, he developed the He then joined WL/PD, where his lab demonstrated the existence of two subtypes of the adenosine A2 receptor In 1988, he joined Lilly as a receptor biologist in charge of a high-throughput screening lab.

During a joint postdoc with John W Daly at NIH and Solomon Snyder at Johns Hopkins, he developed the He then joined WL/PD, where his lab demonstrated the existence of two subtypes of the adenosine A2 receptor In 1988, he joined Lilly as a receptor biologist in charge of a high-throughput screening lab.

About Eric Johansen "I will be a 6th year Ph.D student in the chemical biology interface program at Johns Eric Johansen on the web Johns Hopkins University Dr.

He then went on to earn a Ph.D. in Molecular Biophysics from Johns Hopkins University, followed by postdocs

He then went on to earn a Ph.D. in Molecular Biophysics from Johns Hopkins University, followed by postdocs

John Traynor , Kathryn worked to develop and understand first-in-class allosteric modulators of opioid

John Traynor , Kathryn worked to develop and understand first-in-class allosteric modulators of opioid

progressed through the ranks at Warwick to become an Associate Professor before leaving in 2015 to join the Department of Pharmacology at Cambridge, where he is also a Fellow of St John’s College.

Receptor Pharmacology Unit at the National Institutes of Health – National Institute on Aging at the Johns

To join the community you must be related to the GPCR field. Once in the Dr. Join us today and you’ll get to: Interact directly with your target audience Access to all member perks John Teye Azietaku Business Development & Scientific Associate Get in Touch Balint Bajnoczki Video &

Receptor Pharmacology Unit at the National Institutes of Health – National Institute on Aging at the Johns

He has also been the recipient of multiple awards, including the John J.

He has also been the recipient of multiple awards, including the John J.

Receptor Pharmacology Unit at the National Institutes of Health – National Institute on Aging at the Johns

Receptor Pharmacology Unit at the National Institutes of Health – National Institute on Aging at the Johns

Randy then joined the faculty at the Emory University School of Medicine in 1999. Keck Foundation, and the John J. Abel Award from ASPET . Join me to learn more about Randy’s work, hear his insights on the GPCR field, and also hear the story

for normal alveologenesis and maintenance of lung homeostasis. " Authors Amanda T Goodwin , Alison E John

Authors Mithila Tennakoon , Waruna Thotamune , John L Payton , Ajith Karunarathne Tags HMG-CoA reductase

, Riley E Perszyk , Nicholas H Harbin , Jennifer Okalova , Suneela Ramineni , Stephen F Traynelis , John

If you haven't signed up yet, join over 200 of your colleagues who already did. Join us in the Dr. GPCR Club on LinkedIn. Did you know you can also become a Dr. GPCR member ? John Foley's comments on this paper . Here is an example Call for reviewers for pain and opioid folks: John Streicher is looking for experienced